StockData
MetLife Inc logo

MetLife Inc (MET) stock analysis

METNYSELife InsuranceFiscal year ends December 31Also trades as MET.PA, MET.PE, MET.PF
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 10/3039% above fair value
$102.94+0.50 (+0.49%)

Close on Nov 11, 2026Market cap $65.42BP/E 13.4Yield 2.18%

StockData Score

Prices as of Nov 11, 2026How the score works

Value1Growth2Performance2Health2Dividend3

Mixed10 of 30 checks passed

MetLife passes 10 of the 30 checks behind our score; 6 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
1/6
Growth
2/6
Past performance
2/6
Financial health
2/6
Dividend
3/6

What stands out

  • Low debt

    Debt is 1.3% of shareholders' equity, under the 40% we consider low.

  • Earnings growth accelerating

    Net income grew 33.5% over the last twelve months, against a 5-year average of -9.0% a year.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 4841% of total debt.

  • P/E below its 5-year median

    MetLife's P/E of 13.4 is below its own 5-year median of 14.4.

What to watch

  • Margin of safety under 20%

    The price is 39.2% above fair value, so there is no margin of safety.

  • Trading above fair value

    The share price of $102.94 is above our fair value estimate of $73.93.

  • Return on equity under 15%

    Return on equity was 20.0% over the last twelve months and averaged 10.7% over five years; we look for 15% on both.

  • Earnings shrank over 5 years

    Net income shrank 9.0% a year on average over the last five fiscal years.

Valuation1/6
  • P/E below its 5-year median

    MetLife's P/E of 13.4 is below its own 5-year median of 14.4.

  • P/E above the industry

    MetLife's P/E of 13.4 is above the Life Insurance median of 10.8.

  • P/S above the industry

    MetLife's price-to-sales of 0.79 is above the Life Insurance median of 0.67.

  • P/B above the industry

    MetLife's price-to-book of 2.94 is above the Life Insurance median of 1.11.

  • Trading above fair value

    The share price of $102.94 is above our fair value estimate of $73.93.

  • Margin of safety under 20%

    The price is 39.2% above fair value, so there is no margin of safety.

Growth2/6
  • Revenue growing under 10% a year

    Revenue grew 3.9% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growing under 10% a year

    Diluted EPS grew -9.2% a year over the last three fiscal years.

  • Earnings growth accelerating

    Net income grew 33.5% over the last twelve months, against a 5-year average of -9.0% a year.

  • Growing faster than the industry

    Revenue grew 14.8% over the last twelve months; the Life Insurance median is 7.1%.

  • Company guidance

    No outlook found in earnings releases from the last twelve months.

  • Gross margin trend

    Banks and insurers do not report gross profit.

Past performance2/6
  • Return on equity under 15%

    Return on equity was 20.0% over the last twelve months and averaged 10.7% over five years; we look for 15% on both.

  • Return on assets under 1%

    Return on assets was 0.7%; for a bank or insurer, 1% or more is considered good.

  • Return on equity above the industry

    MetLife's return on equity of 20.0% is above the Life Insurance median of 12.6%.

  • Earnings shrank over 5 years

    Net income shrank 9.0% a year on average over the last five fiscal years.

  • Net margin above its 5-year average

    Net margin was 6.2% over the last twelve months, against a 5-year average of 6.1%.

  • Net margin below the industry

    MetLife's net margin of 6.2% is below the Life Insurance median of 8.1%.

Financial health2/6
  • Low debt

    Debt is 1.3% of shareholders' equity, under the 40% we consider low.

  • Debt rising against equity

    Debt to equity rose from 0.5% five years ago to 1.3%.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 4841% of total debt.

  • Interest coverage

    Interest expense is not reported separately.

  • Short-term liquidity

    Insurers do not split assets into current and non-current.

  • Bankruptcy risk (Altman Z)

    The Altman model does not apply to insurers.

Dividend3/6
  • Pays a dividend

    MetLife paid dividends worth 1.7% of the share price over the last twelve months.

  • Yield below Treasuries

    The 1.7% yield is below the 4.4% on a 1-year Treasury.

  • Yield below the top quarter

    The top quarter of US dividend payers yield 3.8% or more; MetLife yields 1.7%.

  • Dividend not cut

    The dividend per share has not fallen by more than 10% in any of the last 10 fiscal years.

  • Covered by earnings

    Dividends take 29.4% of net income.

  • Cash-flow cover

    Needs dividends paid and free cash flow.

Scores of similar companies

Our estimate per share

$73.93

The share price is 39% above this estimate.

20%+ below
Near fair value
20%+ above
$102.94Price$73.93Fair value
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/E12.6×14.4×10.8×$96.6650%
P/B1.5×1.8×1.1×$51.1950%
Fair value$73.93100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 14.4
  • Life Insurance median 10.8

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Low risk

Average value traded per day
$325.47M
Value traded per 1% price move
$277.69M

Downside

Low risk

Typical loss in a bad month
11.1%
Volatility (annualized)
24%
Sharpe ratio, 1 year
1.21
Beta to the S&P 500 (5Y)
0.87

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2011 to 2025

Operating margin

8.0%

Net margin

4.4%−3.6 pts over 5 years

See a number that looks wrong?